Golden Helix to Sponsor the 2014 Mid-Atlantic Genetic Epidemiology and Statistics Conference

Bozeman, MT (March 18, 2014) — Golden Helix, Inc. today announced their sponsorship of the 2014 Mid-Atlantic Genetic Epidemiology and Statistics (MAGES) Conference: Integrated Systems Biology, Analytical Methods for Epidemiological Studies of Complex Traits. The conference will address the impact of technological advancements along with the decline in cost of genetic analysis and how both facets have now created a need for the ability to analyze different data types together.

“Golden Helix is pleased to expand our involvement with the Perelman School of Medicine at the University of Pennsylvania by sponsoring MAGES,” said Andreas Scherer, President and CEO of Golden Helix. “The conference will bring together many of the community’s thought leaders, and I look forward to hearing new approaches for data integration and to moderating a roundtable on the subject.”

The basis of human disease is complex and as technology advances and costs decline, researchers are able to delve further into genetic data. Being able to effectively utilize and combine the abundance of high-dimensional data is necessary for a unified analytical framework. Researchers within the genetic community will present their experiences with these analytic challenges in three sessions: Analysis of complex datasets, Statistical models for integrated analytical methods, and Future developments in high-dimensional data analysis.

“Understanding the roots of complex human disease requires a multifaceted analytic approach,” said Marcella Devoto, PhD, professor of Pediatrics at The Children’s Hospital of Philadelphia and Epidemiology at the Perelman School of Medicine. “We have organized MAGES as a platform to share and discuss both the challenges and success of integrated genomic analysis.”

MAGES will be held May 30, 2014 in the Colket Translational Research Building at The Children’s Hospital of Philadelphia and is organized by the Center for Genetics and Complex Traits of the Perelman School of Medicine at the University of Pennsylvania. The conference is free to attend and includes lunch and coffee breaks. For more information and registration, please visit the MAGES website at:

Editor’s note: Dr. Devoto reports no financial ties to Golden Helix

About Golden Helix
Golden Helix has been delivering industry leading bioinformatics solutions for the advancement of life science research and translational medicine for over 15 years. Our innovative technologies and analytic services empower scientists and healthcare professionals at all levels to derive meaning from the rapidly increasing volumes of genomic data produced from microarrays and next-generation sequencing. With our solutions, hundreds of the world’s top pharmaceutical, biotech, and academic research organizations are able to harness the full potential of genomics to identify the cause of disease, improve the efficacy and safety of drugs, develop genomic diagnostics, and advance the quest for personalized medicine. Golden Helix products and services have been cited in over 800 peer-reviewed publications.

Jessica Vionas
Director of Marketing
Golden Helix, Inc.